The three-finger toxin MTα is a selective α2B-adrenoceptor antagonist

Toxicon

Volumn 56, Issue 3, 2010, Pages 440-447

  Koivula, Katja ^a   Rondinelli, Sergio ^a   Näsman, Johnny ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Adrenoceptor; Calcium mobilisation; Ligand binding; Muscarinic receptors; Muscarinic toxin

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; METHYLSCOPOLAMINE; MUSCARINIC TOXIN ALPHA; RADIOLIGAND; TRITIUM; UNCLASSIFIED DRUG; ALPHA 2 ADRENERGIC RECEPTOR;

ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CELL CULTURE; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EQUILIBRIUM CONSTANT; IC 50; INHIBITION KINETICS; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; ANIMAL; CELL LINE; DRUG EFFECT; HUMAN; RADIOASSAY;

CROCODYLUS NILOTICUS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CELL LINE; HUMANS; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 77954141714     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.05.001     Document Type: Article

References (36)

1. Adem A., Jolkkonen M., Bogdanovic N., Islam A., Karlsson E. Localization of M1 muscarinic receptors in rat brain using selective muscarinic toxin-1. Brain Res. Bull. 1997, 44:597-601.
2. Adem A., Åsblom A., Johansson G., Mbugua P.M., Karlsson E. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim. Biophys. Acta 1988, 968:340-345.
3. Albrand J.P., Blackledge M.J., Pascaud F., Hollecker M., Marion D. NMR and restrained molecular dynamics study of the three-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium channel, isolated from black mamba venom. Biochemistry 1995, 34:5923-5937.
4. Christopoulos A., Parsons A.M., Lew M.J., El-Fakahany E.E. The assessment of antagonist potency under conditions of transient response kinetics. Eur. J. Pharmacol. 1999, 382:217-227.
5. de Weille J.R., Schweitz H., Maes P., Tartar A., Lazdunski M. Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc. Natl. Acad. Sci. U S A 1991, 88:2437-2440.
6. El-Fakahany E.E., Surichamorn W., Amrhein C.L., Stenstrom S., Cioffi C.L., Richelson E., McKinney M. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine. J. Pharmacol. Exp. Ther. 1988, 247:934-940.
7. Fruchart-Gaillard C., Mourier G., Marquer C., Menez A., Servent D. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7. Mol. Pharmacol. 2006, 69:1641-1651.
8. Fruchart-Gaillard C., Mourier G., Marquer C., Stura E., Birdsall N.J., Servent D. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states. Mol. Pharmacol. 2008, 74:1554-1563.
9. Harvey A.L., Kornisiuk E., Bradley K.N., Cervenansky C., Duran R., Adrover M., Sanchez G., Jerusalinsky D. Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors. Neurochem. Res. 2002, 27:1543-1554.
10. Holmberg C.I., Kukkonen J.P., Bischoff A., Näsman J., Courtney M.J., Michel M.C., Åkerman K.E. Alpha2B-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems. Eur. J. Pharmacol. 1998, 363:65-74.
11. Jansson C.C., Karp M., Oker-Blom C., Näsman J., Savola J.M., Åkerman K.E. Two human alpha 2-adrenoceptor subtypes alpha 2A-C10 and alpha 2B-C2 expressed in Sf9 cells couple to transduction pathway resulting in opposite effects on cAMP production. Eur. J. Pharmacol. 1995, 290:75-83.
12. Jerusalinsky D., Harvey A.L. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 1994, 15:424-430.
13. Jerusalinsky D., Kornisiuk E., Bernabeu R., Izquierdo I., Cervenansky C. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions. Toxicon 1995, 33:389-397.
14. Jolkkonen M., Oras A., Toomela T., Karlsson E., Järv J., Åkerman K.E. Kinetic evidence for different mechanisms of interaction of black mamba toxins MT alpha and MT beta with muscarinic receptors. Toxicon 2001, 39:377-382.
15. Jolkkonen M., Van Giersbergen P.L., Hellman U., Wernstedt C., Oras A., Satyapan N., Adem A., Karlsson E. Muscarinic toxins from the black mamba Dendroaspis polylepis. Eur. J. Biochem. 1995, 234:579-585.
16. Karlsson E., Jolkkonen M., Mulugeta E., Onali P., Adem A. Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie 2000, 82:793-806.
17. Karlsson E., Mbugua P.M., Rodriguez-Ithurralde D. Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps. J. Physiol. (Paris) 1984, 79:232-240.
18. Kornisiuk E., Jerusalinsky D., Cervenansky C., Harvey A.L. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Toxicon 1995, 33:11-18.
19. Kukkonen A., Peräkylä M., Åkerman K.E., Näsman J. Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops. J. Biol. Chem. 2004, 279:50923-50929.
20. Kukkonen J., Åkerman K.E. Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists. Biochem. Biophys. Res. Commun. 1992, 189:919-924.
21. Kukkonen J.P., Näsman J., Ojala P., Oker-Blom C., Åkerman K.E.O. Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system. J. Pharmacol. Exp. Ther. 1996, 279:593-601.
22. Kukkonen J.P., Näsman J., Rinken A., Dementjev A., Åkerman K.E. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists. Biochem. Biophys. Res. Commun. 1998, 243:41-46.
23. Max S.I., Liang J.S., Potter L.T. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J. Neurosci. 1993, 13:4293-4300.
24. Max S.I., Liang J.S., Potter L.T. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol. Pharmacol. 1993, 44:1171-1175.
25. Max S.I., Liang J.S., Valentine H.H., Potter L.T. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J. Pharmacol. Exp. Ther. 1993, 267:480-485.
26. McDowell R.S., Dennis M.S., Louie A., Shuster M., Mulkerrin M.G., Lazarus R.A. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry 1992, 31:4766-4772.
27. Mourier G., Dutertre S., Fruchart-Gaillard C., Menez A., Servent D. Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor. Mol. Pharmacol. 2003, 63:26-35.
28. Näsman J., Jolkkonen M., Ammoun S., Karlsson E., Åkerman K.E. Recombinant expression of a selective blocker of M(1) muscarinic receptors. Biochem. Biophys. Res. Commun. 2000, 271:435-439.
29. Oker-Blom C., Jansson C., Karp M., Lindqvist C., Savola J.M., Vlak J., Åkerman K. Functional analysis of the human alpha 2C-C4 adrenergic receptor in insect cells expressed by a luciferase-based baculovirus vector. Biochim. Biophys. Acta 1993, 1176:269-275.
30. Olianas M.C., Adem A., Karlsson E., Onali P. Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors. Eur. J. Pharmacol. 2004, 487:65-72.
31. Quinton L., Girard E., Maiga A., Rekik M., Lluel P., Masuyer G., Larregola M., Marquer C., Ciolek J., Magnin T., Wagner R., Molgo J., Thai R., Fruchart-Gaillard C., Mourier G., Chamot-Rooke J., Menez A., Palea S., Servent D., Gilles N. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha(1A)-adrenoceptor. Br. J. Pharmacol. 2010, 159:316-325.
32. Santiago M.P., Potter L.T. Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons. Brain Res. 2001, 894:12-20.
33. Schweitz H., Moinier D. Mamba toxins. Perspect. Drug Discov. Des. 1999, 15/16:83-110.
34. Theroux T.L., Esbenshade T.A., Peavy R.D., Minneman K.P. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol. Pharmacol. 1996, 50:1376-1387.
35. Toomela T., Jolkkonen M., Rinken A., Jarv J., Karlsson E. Two-step binding of green mamba toxin to muscarinic acetylcholine receptor. FEBS Lett. 1994, 352:95-97.
36. Waelbroeck M., De Neef P., Domenach V., Vandermeers-Piret M.C., Vandermeers A. Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors. Eur. J. Pharmacol. 1996, 305:187-192.